Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg Exporter

Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg Exporter in India – Healthy Inc

Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg Exporter product packaging

Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg | Exporter

Product image for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg Exporter; regulatory dossiers & international shipping.

Product Information

Generic NameParacetamol and Orphenadrine Citrate
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049099
PharmacopoeiaIP / BP
Product TypeTablet
CategoryAnalgesic and Muscle Relaxant Combination
SubcategoryAnalgesic and Muscle Relaxant Combination
Active IngredientParacetamol and Orphenadrine Citrate
Strength35 mg + 450 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAnalgesic and Muscle Relaxant Combination

Medicine Details & Safety

Short DescriptionHealthy Inc invites international procurement enquiries for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.
Approved Uses / Indications1. Relief of pain and functional stiffness in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. 2. Management of acute painful musculoskeletal disorders, tenosynovitis, lumbago, dentalgia, and post-traumatic injury.
Full Description

Healthy Inc invites international procurement enquiries for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.

Product technical specifications

Generic nameParacetamol and Orphenadrine Citrate
CompositionParacetamol and Orphenadrine Citrate
Strength35 mg + 450 mg
CategoryAnalgesic and Muscle Relaxant Combination
PharmacopoeiaIP / BP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Export regulatory and dossier readiness

Identify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.

Climatic zone stability and export artwork

For Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.

Global logistics and trade terms

Specify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.

International buyer requirements

Enquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations.
Dosage InstructionsAdminister orally with a full glass of water, preferably with or immediately following meals to minimize gastric irritation. Do not exceed the maximum prescribed daily dosage. Use the lowest effective dose for the shortest treatment duration necessary.
Side EffectsCommon: Epigastric discomfort, dyspepsia, heartburn, nausea, abdominal pain. Uncommon: Dizziness, headache, mild diarrhea, flatulence, constipation. Rare: Peptic ulceration, gastrointestinal hemorrhage, elevated transaminases, hypersensitivity rash.
Warnings and PrecautionsGastrointestinal Safety: Long-term administration can lead to gastric mucosal erosion, ulceration, or bleeding. Cardiovascular & Renal Caution: Use with caution in patients with preexisting hypertension, congestive heart failure, or renal compromise. Monitor renal parameters periodically.
Contraindications1. Known hypersensitivity to Paracetamol and Orphenadrine Citrate, aspirin, or other NSAIDs.
2. Active peptic ulcer disease, gastrointestinal hemorrhage, or history of perforation.
3. Severe heart failure (NYHA Class III-IV), severe hepatic cirrhosis, or advanced renal failure.
4. Third trimester of pregnancy.
Drug Interactions1. Anticoagulants & Antiplatelets (Warfarin, Clopidogrel): Increased risk of serious GI bleeding.
2. ACE Inhibitors, ARBs & Diuretics: Attenuated antihypertensive efficacy and increased nephrotoxicity risk.
3. Methotrexate & Lithium: Reduced renal clearance causing elevated serum concentrations and toxicity.

Frequently Asked Questions

QuestionAnswer
Which registration documents can be requested for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg?Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review.
Is Zone IVb data available for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg?Request confirmation for the exact formulation and packaging configuration.
Can export artwork be multilingual for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg?Provide the required languages and approved regulatory artwork for review.
Which shipping terms can be discussed for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg?EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement.
How do I obtain an export quotation for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg?Provide destination country, quantity, documentation requirements and preferred trade terms.

Product Hashtags

#Paracetamol#Exporter#PharmaB2B

Related Products

Latest Posts